Yunqi Hu
Key Laboratory For Stem Cells And Tissue Engineering
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
M protein ectodomain-specific immunity restrains SARS-CoV-2 variants replication.
Journal: Frontiers in immunology
Published: June 16, 2024
Unveiling the micronutrient-immunity puzzle in inactivated COVID-19 vaccination: A comprehensive analysis of circulating micronutrient levels and humoral responses in healthy adults.
Journal: Journal of medical virology
Published: January 30, 2024
Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants including JN.1.
Journal: Signal transduction and targeted therapy
Published: December 11, 2023
RBD class 1 and 2 antibody epitopes elicit around 70% neutralizing capacity against SARS-CoV-2 virus following boosting with inactivated virus vaccine.
Journal: Vaccine
Published: June 22, 2023
Spike substitution T813S increases Sarbecovirus fusogenicity by enhancing the usage of TMPRSS2.
Journal: PLoS pathogens
Published: January 14, 2023
Comparative global B cell receptor repertoire difference induced by SARS-CoV-2 infection or vaccination via single-cell V(D)J sequencing.
Journal: Emerging microbes & infections
Published: July 28, 2022
A triple-RBD-based mucosal vaccine provides broad protection against SARS-CoV-2 variants of concern.
A triple-RBD-based mucosal vaccine provides broad protection against SARS-CoV-2 variants of concern.
Journal: Cellular & molecular immunology
Published: July 15, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026